Estimates Revisions Ionis Pharmaceuticals, Inc.
Stocks
IONS
US4622221004
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
14:34:16 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 57.89 USD | -5.61% |
|
-7.18% | -26.75% |
| 06:35am | Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial | RE |
| 08-31 | Trump administration to announce drug pricing deals | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- IONS Stock
- Consensus Ionis Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
